Regulating Compounding in the GLP-1 Era: A Conversatio | Essential: The Pharmacy Compounding Podcast
This episode we look at a bunch of statements from the FDA and from HHS Secretary Robert F. Kennedy, Jr. And of course there are peptides to talk about these days. Does anyone really know what’s going on with those? Our deep dive is a special one: Our guest is Al Carter, the CEO of the National Association of Boards of Pharmacy, and he gives us a totally different perspective on the regulatory landscape at the level that affects pharmacists every day. Links from the podcast: The latest FDA statement on DTE: https://fllw.me/4sL6zXw The Coalition for Compounding Excellence’s first audit process guide (compounding records and quality control): https://fllw.me/3Oew1qr FDA Law Blog on the state of peptide compounding: https://fllw.me/4cpFF2C National Association of Boards of Pharmacy: https://nabp.pharmacy Join APC! https://a4pc.org/join
You May Also Like

Global News Today | 2 Min News | The Daily News Now!
The Daily News Now!

700 WLW On-Demand
WLW-AM (WLWAM)

Israel Today: Ongoing War Report
Israel Today: Ongoing War Report

The Pete Quiñones Show
Peter R Quiñones

The Epstein Chronicles
Bobby Capucci

Le journal d'Europe 1
Europe 1

28 Minutes
ARTE Radio

SBS Arabic - أس بي أس عربي
SBS

The True Crime Tapes
Bobby Capucci

The Dishcast with Andrew Sullivan
Andrew Sullivan
Community discussion